Most cited papers from Klinik Hietzing

Klinik Hietzing

What are the most cited papers from Klinik Hietzing?

The most cited paper from Klinik Hietzing is "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update" (Josef S Smolen et al., 2017), with 5,808 citations. Next come "Rheumatoid arthritis" (4,910) and "Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations" (2,677).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 359 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access	6 Mar 2017	5,808
2	Rheumatoid arthritis Josef S Smolen, Daniel Aletaha, Iain B. McInnes · The Lancet	3 May 2016	4,910
3	Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations H. Bernheimer, Walther Birkmayer, Oleh Hornykiewicz et al. · Journal of the Neurological Sciences	Dec 1973	2,677
4	Treating rheumatoid arthritis to target: recommendations of an international task force Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access	10 Mar 2010	2,115
5	\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Josef S Smolen et al. · Radboud Repository (Radboud University)	2010	1,632
6	Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access	12 May 2015	1,484
7	The relation between inflammation and neurodegeneration in multiple sclerosis brains Josa Maria Frischer, Stephan Bramow, Assunta Dal‐Bianco et al. · Brain Open access	31 Mar 2009	1,450
8	Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community Claudio Vitali et al. · Arthritis & Rheumatism	Mar 1993	1,447
9	Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial Josef S Smolen, André D. Beaulieu, Andrea Rubbert‐Roth et al. · The Lancet	Mar 2008	1,418
10	Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score Daniel Aletaha, Valerie P. K. Nell, Tanja Stamm et al. · Arthritis Research & Therapy Open access	7 Apr 2005	1,089
11	Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide Frédéric Houssiau et al. · Arthritis & Rheumatism Open access	Aug 2002	1,080
12	A simplified disease activity index for rheumatoid arthritis for use in clinical practice Josef S Smolen, FC Breedveld, Michael H. Schiff et al. · Lara D. Veeken	Feb 2003	1,078
13	New therapies for treatment of rheumatoid arthritis Josef S Smolen, Daniel Aletaha, Marcus Koeller et al. · The Lancet	14 Jun 2007	1,004
14	EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update Laure Gossec et al. · Annals of the Rheumatic Diseases Open access	Jun 2020	960
15	Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal Joop P. van de Merwe, Jørgen Nordling, Pierre Nourdine Bouchelouche et al. · European Urology	21 Sep 2007	960
16	European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update Laure Gossec et al. · Annals of the Rheumatic Diseases Open access	10 Feb 2016	923
17	Therapeutic strategies for rheumatoid arthritis Josef S Smolen, G Steiner · Nature Reviews Drug Discovery Review	30 May 2003	921
18	Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis Barbara Kornek, Maria K. Storch, Robert Weissert et al. · American Journal Of Pathology Open access	Jul 2000	920
19	Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate George A. Wells, J-C Becker, J. Teng et al. · Annals of the Rheumatic Diseases Open access	19 May 2008	910
20	Remyelination is extensive in a subset of multiple sclerosis patients Peter T. Patrikios, Christine Stadelmann, Alexandra Kutzelnigg et al. · Brain Open access	9 Jun 2006	813
21	American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials David T. Felson et al. · Annals of the Rheumatic Diseases Open access	3 Feb 2011	783
22	Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis Sofía Ramiro, Cécile Gaujoux-Viala, Jackie L Nam et al. · Annals of the Rheumatic Diseases ReviewOpen access	9 Jan 2014	712
23	Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010 Daniel E. Fürst, Edward Clark Keystone, Jürgen Braun et al. · Annals of the Rheumatic Diseases	21 Feb 2011	691
24	Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access	7 Jul 2017	688
25	Pathology of Parkinson’s disease K. A. Jellinger · Molecular and Chemical Neuropathology	Jun 1991	682
26	Time course of nigrostriatal degeneration in parkinson's disease Peter Franz Riederer, St. Wuketich · Journal of Neural Transmission	Sep 1976	574
27	Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial Rafael Bañares et al. · Hepatology Open access	5 Dec 2012	568
28	Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial Michael Gnant et al. · The Lancet Open access	31 May 2015	566
29	The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide Frédéric Houssiau et al. · Annals of the Rheumatic Diseases Open access	21 Jan 2009	544
30	Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial Josef S Smolen, Jonathan Kay, Mittie K. Doyle et al. · The Lancet	27 Jun 2009	525
31	Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score Monika Schoels, Daniel Aletaha, Farideh Mohammadi Alasti et al. · Annals of the Rheumatic Diseases Open access	12 Aug 2015	504
32	Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial Josef S Smolen, R. B. M. Landewé, Philip J. Mease et al. · Annals of the Rheumatic Diseases Open access	18 Nov 2008	496
33	The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial the SWITCH Study Group, Tadej Battelino, Ignacio Conget et al. · Diabetologia Open access	10 Sep 2012	495
34	The standardized EEG electrode array of the IFCN Margitta Seeck, Laurent Koessler, Thomas Bast et al. · Clinical Neurophysiology Open access	17 Jul 2017	489
35	Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Wolfgang Pf Miehsler, W Reinisch, E Valic et al. · Gut Open access	11 Mar 2004	482
36	ESPEN guidelines on nutrition in dementia Dorothee Volkert, Michael Chourdakis, Gerd Faxén Irving et al. · Clinical Nutrition Open access	26 Sep 2015	463
37	Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ Hans Lassmann, C. Bancher, Helene Breitschopf et al. · Acta Neuropathologica	1995	458
38	Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update Michaela Alexandra Stoffer, Monika Schoels, Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access	20 May 2015	454
39	Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis Maya H Buch, Josef S Smolen, Neil Betteridge et al. · Annals of the Rheumatic Diseases Open access	7 Mar 2011	453
40	Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access	8 Jun 2013	449
41	European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies Laure Gossec et al. · Annals of the Rheumatic Diseases Open access	28 Sep 2011	448
42	Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial Josef S Smolen, Désirée M F M van der Heijde, E. William St. Clair et al. · Arthritis & Rheumatism	28 Feb 2006	439
43	Activation of Caspase-3 in Single Neurons and Autophagic Granules of Granulovacuolar Degeneration in Alzheimer's Disease Christine Stadelmann, Thomas L. Deckwerth, Anu N. Srinivasan et al. · American Journal Of Pathology Open access	Nov 1999	433
44	Neuropathological Diagnostic Criteria for Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) Herbert Budka, Adriano Aguzzi, Paul Brown et al. · Brain Pathology Open access	Oct 1995	432
45	Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis Monika Schoels, Daniel Aletaha, Julia Funovits et al. · Annals of the Rheumatic Diseases	4 Jun 2010	429
46	A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative Laure Gossec et al. · Annals of the Rheumatic Diseases Open access	30 Apr 2014	425
47	EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations Alexander Nast et al. · Journal of the European Academy of Dermatology and Venereology Open access	Nov 2020	420
48	EAU Guidelines on Urological Trauma T LYNCH, Luis Martínez‐Piñeiro, Eugen Plas et al. · European Urology	27 Aug 2004	412
49	Alterations in Nocturnal Serum Melatonin Levels In Humans With Growth and Aging* Franz Waldhauser, Gunther Weiszenbacher, Ernst Tatzer et al. · The Journal of Clinical Endocrinology & Metabolism	Mar 1988	412
50	Thoracic Endovascular Aortic Repair (TEVAR) for the treatment of aortic diseases: a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Martin Grabenwöger, Fernándo Alfonso, Jean E. Bachet et al. · European Heart Journal Open access	4 May 2012	412

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.